Jiangsu Hengrui Medicine Co., Ltd. is China's largest listed pharmaceutical company, founded in 1970, with over 20,000 employees globally. Hengrui is primarily an innovation-driven pharma company developing and manufacturing its own drugs across oncology, cardiovascular, metabolism, autoimmune, pain, and anti-infection therapeutic areas, with a pipeline of 257 drugs and 24 Class 1 innovative drugs. While it has some CDMO references in search results, Perplexity research confirms it primarily specializes in proprietary drug development and manufacturing rather than contract services.
innovative oncology drug development, small molecule and biologic drug R&D, global clinical trials (35 FDA-listed), sterile injectable manufacturing
1 site worldwide
Involvement in 35 clinical trials
No reviews available yet.
No documents available.